Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 214 for head and neck

Edit search filters
  1. Cetuximab With Or Without Tivantinib In Treating Patients With Head And Neck Cancer That Is Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Evaluate The Safety And Effectiveness Of Tipifarnib In Head And Neck Cancer With HRAS Mutations And Impact Of HRAS On Response To Therapy

    Rochester, MN

  3. A Study to Evaluate Remote Objective Monitoring

    Rochester, MN

  4. Study Of MK-3475 (Pembrolizumab) In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma After Treatment With Platinum-based And Cetuximab Therapy (MK-3475-055/KEYNOTE-055)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Chemotherapy Plus Cetuximab In Combination With VTX-2337 In Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

    Scottsdale/Phoenix, AZ

  6. High-dose Prophylactic Gabapentin (HOPE) Vs. Placebo To Prevent Opioid Use For Oral Mucositis Pain During Concurrent Chemoradiation For Head And Neck Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  7. Viral Therapy In Treating Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck Cancer Or Metastatic Breast Cancer

    Rochester, MN

  8. Patient Satisfaction In Mohs Micrographic Surgery With Supplemental Lidocaine Jelly

    Scottsdale/Phoenix, AZ

  9. Radiation Therapy With Or Without Cisplatin In Treating Patients With Stage III-IV Squamous Cell Carcinoma Of The Head And Neck Who Have Undergone Surgery

    Rochester, MN

  10. Study Of Nivolumab In Combination With Ipilimumab Versus Nivolumab In Combination With Ipilimumab Placebo In Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

    Rochester, MN

.

Mayo Clinic Footer